WeVote
Log In

Bill

TB

Bill

HR 9949

Safe Baby Formula Act of 2026

119th Congress Introduced by Tom Barrett

The bill would require a HHS study on health effects of arsenic, cadmium, mercury, and lead in infant formula and set regulatory standards to limit these contaminants.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 9949

Overview

HR 9949 (119th Congress) seeks to require the Secretary of Health and Human Services to conduct a study on the health impacts of four contaminants—arsenic, cadmium, mercury, and lead—in infant formula and to establish standards for regulating their content in infant formula. The bill was introduced in the House and referred to the House Committee on Energy and Commerce. It has at least one co-sponsor (Tom Barrett).

Main purpose and intent

  • To commission a formal study by the Secretary of Health and Human Services assessing how exposure to arsenic, cadmium, mercury, and lead in infant formula affects infant health.
  • To establish regulatory standards detailing permissible levels of these four contaminants in infant formula, aiming to protect infant health and guide oversight.

Key provisions and changes

  • Study mandate:
    • The Secretary of Health and Human Services must conduct a study on the health impacts of arsenic, cadmium, mercury, and lead in infant formula.
    • The study would presumably evaluate exposure pathways, risk characterization, vulnerable populations (e.g., very young infants), health outcomes, and potential mitigation strategies.
  • Regulatory standards:
    • Following or based on the study, the bill would require the establishment of standards for regulating the content of arsenic, cadmium, mercury, and lead in infant formula.
    • These standards could set permissible concentration limits or maximum allowable levels in infant formula products.
  • Administrative framework:
    • The bill designates the Department of Health and Human Services as the responsible federal agency to conduct the study and oversee the development and enforcement of standards.

Who/what would be affected

  • Infants and families: The primary beneficiaries would be infants consuming formula, as standards aim to reduce toxic exposure.
  • Infant formula manufacturers: Industry players would be subject to new regulatory standards and potential compliance requirements, testing, labeling, and quality controls.
  • Federal regulatory agencies: The Department of Health and Human Services would lead the study and regulatory framework, potentially involving collaboration with other agencies such as the FDA (within HHS) or related entities during implementation.
  • Public health and pediatric care: Findings could influence pediatric guidance, nutrition recommendations, and monitoring programs regarding infant formula safety.

Procedural and timeline notes

  • Introduction and referral:
    • Introduced in the House and referred to the Committee on Energy and Commerce (2026-07-27).
  • Legislative process:
    • As a bill in early stages, it would require committee consideration, potential amendments, passage by both House and Senate, and presidential signature to become law.
  • Timelines:
    • The bill text does not specify explicit deadlines for the study or for implementing standards within the provided summary. If enacted, the final act would likely set specific milestones, reporting deadlines, and a phased timeline for standard development and compliance.

Potential impact and considerations

  • Health protection: If enacted, the study could inform evidence-based regulatory limits for heavy metals in infant formula, potentially reducing exposure and associated health risks for infants.
  • Industry impact: Manufacturers may need to invest in testing, sourcing of lower-contaminant ingredients, and reformulation to meet new standards, with potential cost implications.
  • Data and outcomes: The scope and rigor of the study (sample size, methodologies, timelines) will influence the credibility and enforceability of resulting standards.
  • Stakeholder engagement: Effective implementation would likely require collaboration with regulatory, scientific, and industry stakeholders to establish feasible and science-based limits.

Note: The summary reflects the bill’s stated objectives and provisions as available in the action history and title. Specific legislative text (definitions, exact standards, oversight mechanisms, funding, and enforcement details) would provide further detail once available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.